BeOne Medicines
ONC
#691
Rank
NZ$58.70 B
Marketcap
NZ$530.51
Share price
0.57%
Change (1 day)
70.60%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): NZ$0.98

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is NZ$1.13. In 2024 the company made an earnings per share (EPS) of NZ-$10.82.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$0.98-109.03%
2024NZ-$10.82
2022NZ-$33.8028.21%
2021NZ-$26.37-19.96%
2020NZ-$32.9420.81%
2019NZ-$27.2731.52%
2018NZ-$20.73417.57%
2017NZ-$4.01-37.16%
2016NZ-$6.37158.95%
2015NZ-$2.46

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
NZ-$1.65-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
NZ-$0.42-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA